JP2023518985A5 - - Google Patents
Info
- Publication number
- JP2023518985A5 JP2023518985A5 JP2022558110A JP2022558110A JP2023518985A5 JP 2023518985 A5 JP2023518985 A5 JP 2023518985A5 JP 2022558110 A JP2022558110 A JP 2022558110A JP 2022558110 A JP2022558110 A JP 2022558110A JP 2023518985 A5 JP2023518985 A5 JP 2023518985A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- item
- pharmaceutically acceptable
- alkyl
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154013A JP2025181861A (ja) | 2020-03-27 | 2025-09-17 | 新規脂質及びそれらのナノ粒子組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000990P | 2020-03-27 | 2020-03-27 | |
| US63/000,990 | 2020-03-27 | ||
| PCT/US2021/024413 WO2021195529A2 (en) | 2020-03-27 | 2021-03-26 | Novel lipids and nanoparticle compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154013A Division JP2025181861A (ja) | 2020-03-27 | 2025-09-17 | 新規脂質及びそれらのナノ粒子組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518985A JP2023518985A (ja) | 2023-05-09 |
| JP2023518985A5 true JP2023518985A5 (cg-RX-API-DMAC7.html) | 2024-04-04 |
| JP7746280B2 JP7746280B2 (ja) | 2025-09-30 |
Family
ID=77890624
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558110A Active JP7746280B2 (ja) | 2020-03-27 | 2021-03-26 | 新規脂質及びそれらのナノ粒子組成物 |
| JP2025154013A Pending JP2025181861A (ja) | 2020-03-27 | 2025-09-17 | 新規脂質及びそれらのナノ粒子組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154013A Pending JP2025181861A (ja) | 2020-03-27 | 2025-09-17 | 新規脂質及びそれらのナノ粒子組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US12534435B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4125821A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7746280B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220160647A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115916163A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021241696B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022019369A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173126A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296763B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022011988A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021195529A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| US12534435B2 (en) * | 2020-03-27 | 2026-01-27 | Generation Bio Co. | Lipids and nanoparticle compositions thereof |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| CN118251212A (zh) * | 2021-09-30 | 2024-06-25 | 日油株式会社 | 用于将核酸递送至淋巴管内皮细胞的脂质纳米颗粒 |
| WO2023121964A1 (en) * | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| JPWO2023190164A1 (cg-RX-API-DMAC7.html) * | 2022-03-28 | 2023-10-05 | ||
| CA3247022A1 (en) | 2022-03-28 | 2025-07-08 | National University Corporation Chiba University | METHOD FOR PRODUCING LIPID NANOPARTICLES ENCAPSULATED IN A NUCLEIC ACID, METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO A CELL OR A TARGET CELL |
| WO2023190175A1 (ja) | 2022-03-28 | 2023-10-05 | 日油株式会社 | 末梢血単核細胞へ核酸を送達するための脂質ナノ粒子およびこれを用いて末梢血単核細胞へ核酸を送達する方法 |
| JPWO2023190176A1 (cg-RX-API-DMAC7.html) | 2022-03-28 | 2023-10-05 | ||
| WO2023230587A2 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| KR20250038709A (ko) | 2022-07-15 | 2025-03-19 | 니치유 가부시키가이샤 | 지질 나노입자 및 이의 제조 방법, 핵산-캡슐화 지질 나노입자 및 이의 제조 방법, 및 핵산-캡슐화 지질 나노입자를 사용하여 생체에서 획득 면역을 유도하는 방법 |
| KR20250037535A (ko) | 2022-07-15 | 2025-03-17 | 니치유 가부시키가이샤 | 핵산-로딩된 지질 나노입자의 동결건조 조성물 |
| WO2024192528A1 (en) * | 2023-03-22 | 2024-09-26 | Nanovation Therapeutics Inc. | Ionizable anionic lipids |
| WO2024203660A1 (ja) | 2023-03-29 | 2024-10-03 | 国立大学法人東北大学 | 核酸内封脂質ナノ粒子の製造方法 |
| CN116082184B (zh) * | 2023-04-12 | 2023-06-30 | 山东大学 | 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025043146A2 (en) * | 2023-08-24 | 2025-02-27 | Molecular Axiom Inc. | Lipid nanoparticle compositions and methods of using same |
| CN121909024A (zh) | 2023-09-22 | 2026-04-21 | 国立大学法人东北大学 | 包封有核酸的配体修饰脂质纳米颗粒的制造方法 |
| US20260234104A1 (en) * | 2023-12-15 | 2026-08-13 | Xiamen Sinopeg Biotech Co., Ltd. | Degradable cationic lipid containing a disulfide bond and applications thereof |
| WO2025150516A1 (ja) | 2024-01-12 | 2025-07-17 | 日油株式会社 | 核酸内封脂質ナノ粒子を含む凍結組成物 |
| CN117964577B (zh) * | 2024-03-29 | 2024-06-21 | 天津全和诚生物技术有限公司 | 阳离子脂质化合物、其制备方法、包含其的组合物及应用 |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026070952A1 (ja) * | 2024-09-27 | 2026-04-02 | 日油株式会社 | ジスルフィド結合を有する化合物およびその製造方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| CA2289702C (en) | 1997-05-14 | 2008-02-19 | Inex Pharmaceuticals Corp. | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| US6320017B1 (en) | 1997-12-23 | 2001-11-20 | Inex Pharmaceuticals Corp. | Polyamide oligomers |
| AU6814901A (en) | 2000-06-01 | 2001-12-11 | Univ North Carolina | Methods and compounds for controlled release of recombinant parvovirus vectors |
| WO2002087541A1 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Lipid-based formulations for gene transfer |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| CN1882693B (zh) | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| WO2008103276A2 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP2310440A4 (en) | 2008-07-10 | 2013-06-05 | Serina Therapeutics Inc | POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS |
| EP3391877A1 (en) | 2010-04-08 | 2018-10-24 | The Trustees of Princeton University | Preparation of lipid nanoparticles |
| WO2011139911A2 (en) | 2010-04-29 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
| US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US20120225129A1 (en) | 2010-08-20 | 2012-09-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| WO2012046265A1 (ja) * | 2010-10-05 | 2012-04-12 | トヨタ自動車株式会社 | 推定装置および推定方法 |
| EP2500434A1 (en) | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| CA2853689C (en) | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| WO2013073480A1 (ja) * | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| US9035039B2 (en) * | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
| TWI595885B (zh) | 2012-05-02 | 2017-08-21 | 喜納製藥公司 | 包含四galnac之新穎結合物及傳送寡核苷酸之方法 |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| HUE067372T2 (hu) | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| WO2017084987A1 (en) | 2015-11-16 | 2017-05-26 | F. Hoffmann-La Roche Ag | GalNAc CLUSTER PHOSPHORAMIDITE |
| DK3386484T3 (da) | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| IL261524B2 (en) | 2016-03-03 | 2023-10-01 | Univ Massachusetts | End-capped linear double-stranded DNA for non-viral gene transfer |
| JP2019151589A (ja) * | 2018-03-02 | 2019-09-12 | 国立大学法人北海道大学 | 脂質ナノ粒子 |
| CA3094057C (en) * | 2018-03-27 | 2025-04-08 | Nof Corporation | CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS |
| JP7075256B2 (ja) * | 2018-03-28 | 2022-05-25 | 三菱重工業株式会社 | 配管の余寿命評価方法 |
| CN114929205B (zh) | 2019-09-06 | 2024-09-03 | 世代生物公司 | 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法 |
| US12534435B2 (en) | 2020-03-27 | 2026-01-27 | Generation Bio Co. | Lipids and nanoparticle compositions thereof |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
-
2021
- 2021-03-26 US US17/913,498 patent/US12534435B2/en active Active
- 2021-03-26 WO PCT/US2021/024413 patent/WO2021195529A2/en not_active Ceased
- 2021-03-26 EP EP21776608.8A patent/EP4125821A4/en active Pending
- 2021-03-26 KR KR1020227037604A patent/KR20220160647A/ko active Pending
- 2021-03-26 CA CA3173126A patent/CA3173126A1/en active Pending
- 2021-03-26 CN CN202180037847.5A patent/CN115916163A/zh active Pending
- 2021-03-26 MX MX2022011988A patent/MX2022011988A/es unknown
- 2021-03-26 BR BR112022019369A patent/BR112022019369A2/pt unknown
- 2021-03-26 JP JP2022558110A patent/JP7746280B2/ja active Active
- 2021-03-26 IL IL296763A patent/IL296763B2/en unknown
- 2021-03-26 AU AU2021241696A patent/AU2021241696B2/en active Active
-
2024
- 2024-04-24 US US18/644,728 patent/US12252470B2/en active Active
-
2025
- 2025-01-31 US US19/042,351 patent/US20250361208A1/en active Pending
- 2025-09-17 JP JP2025154013A patent/JP2025181861A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502576A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546597A5 (cg-RX-API-DMAC7.html) | ||
| JP2024517644A5 (cg-RX-API-DMAC7.html) | ||
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| JP2024522692A5 (cg-RX-API-DMAC7.html) | ||
| JP2023534043A5 (cg-RX-API-DMAC7.html) | ||
| JP2023527747A5 (cg-RX-API-DMAC7.html) | ||
| KR20230052895A (ko) | 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형 | |
| US20240293574A1 (en) | Cationic lipids and compositions thereof | |
| WO2021046265A1 (en) | Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof | |
| US20240226325A1 (en) | Cationic lipids and compositions thereof | |
| US20230181764A1 (en) | Novel lipids and nanoparticle compositions thereof | |
| RU2023129760A (ru) | Катионные липиды и их композиции | |
| RU2023135629A (ru) | Катионные липиды и их композиции |